190 related articles for article (PubMed ID: 35401884)
1. Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma.
Yin X; Chen H; Chen S; Zhang S
Dis Markers; 2022; 2022():3736104. PubMed ID: 35401884
[TBL] [Abstract][Full Text] [Related]
2. Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index.
Bai KH; He SY; Shu LL; Wang WD; Lin SY; Zhang QY; Li L; Cheng L; Dai YJ
Cancer Med; 2020 Jun; 9(12):4290-4298. PubMed ID: 32311840
[TBL] [Abstract][Full Text] [Related]
3. Identification of PPAR-related differentially expressed genes liver hepatocellular carcinoma and construction of a prognostic model based on data analysis and molecular docking.
Wang Y; Li S; Liu Z; Li X; Yu Y; Liu H
J Cell Mol Med; 2024 Apr; 28(8):e18304. PubMed ID: 38652093
[TBL] [Abstract][Full Text] [Related]
4. Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.
Wang R; Hu X; Liu X; Bai L; Gu J; Li Q
PLoS One; 2021; 16(4):e0249881. PubMed ID: 33861762
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of CDCA4 in liver hepatocellular carcinoma using bioinformatics analysis and experiments.
Liang C; Long K; Zheng W; Zhong R; Li Z; Zhu S; Gu S; Zhu C; Yang Y
Medicine (Baltimore); 2024 May; 103(18):e38028. PubMed ID: 38701314
[TBL] [Abstract][Full Text] [Related]
6. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma.
Chang Q; Xu Y; Wang J; Jing H; Rao L; Tang W; Zhang Z; Wu X
Comput Math Methods Med; 2021; 2021():8556888. PubMed ID: 34819993
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of N
Zhu HX; Lu WJ; Zhu WP; Yu S
J Clin Lab Anal; 2021 Dec; 35(12):e24071. PubMed ID: 34741346
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.
Shi L; Shang X; Nie K; Lin Z; Zheng M; Wang M; Yuan H; Zhu Z
J Clin Pathol; 2021 Aug; 74(8):504-512. PubMed ID: 33004423
[TBL] [Abstract][Full Text] [Related]
9. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
Chen G; Mo S; Yuan D
Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
[TBL] [Abstract][Full Text] [Related]
10. Exploration of prognostic index based on immune-related genes in patients with liver hepatocellular carcinoma.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32579175
[TBL] [Abstract][Full Text] [Related]
11. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
Ye K; Ouyang X; Wang Z; Yao L; Zhang G
DNA Cell Biol; 2020 Mar; 39(3):474-483. PubMed ID: 31968181
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analysis of the Prognostic Significance of VPS16 in Hepatocellular Carcinoma and Its Role in Drug Screening.
Gong X; Chen T; Lin C; Ping H; Tong X; Zhang K; Chen Z; Cai C; Lu Z; Ke H
Biomed Res Int; 2023; 2023():2501596. PubMed ID: 37124933
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis identifies DYNC1I1 as prognosis marker in male patients with liver hepatocellular carcinoma.
Zhou J; Zhu Y; Ma S; Li Y; Liu K; Xu S; Li X; Li L; Hu J; Liu Y
PLoS One; 2021; 16(10):e0258797. PubMed ID: 34679093
[TBL] [Abstract][Full Text] [Related]
14. miR-381 Reverses Multidrug Resistance by Negative Regulation of the
Pu B; Yu X; Cao Y; Li Y; Tang L; Xia J
DNA Cell Biol; 2021 Dec; 40(12):1584-1596. PubMed ID: 34931867
[TBL] [Abstract][Full Text] [Related]
15. A novel microRNA signature predicts survival in liver hepatocellular carcinoma after hepatectomy.
Fu Q; Yang F; Xiang T; Huai G; Yang X; Wei L; Yang H; Deng S
Sci Rep; 2018 May; 8(1):7933. PubMed ID: 29785036
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive intratumoral heterogeneity landscaping of liver hepatocellular carcinoma and discerning of APLP2 in cancer progression.
Tao Z; Huang J; Li J
Environ Toxicol; 2024 Feb; 39(2):612-625. PubMed ID: 37515494
[TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated m6A methylation of ASPM drives hepatocellular carcinoma cells growth and metastasis.
Wang A; Chen X; Li D; Yang L; Jiang J
J Clin Lab Anal; 2021 Sep; 35(9):e23931. PubMed ID: 34398984
[TBL] [Abstract][Full Text] [Related]
18. LncRNA F11-AS1 suppresses liver hepatocellular carcinoma progression by competitively binding with miR-3146 to regulate PTEN expression.
Du J; Chen M; Liu J; Hu P; Guan H; Jiao X
J Cell Biochem; 2019 Oct; 120(10):18457-18464. PubMed ID: 31168823
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analysis of signaling pathways targeted by Ellagic acid in hepatocellular carcinoma cells.
Qiu S; Zhong C; Zhao B; Li G; Wang J; Jehan S; Li J; Zhao X; Li D; Sui G
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129911. PubMed ID: 33862123
[TBL] [Abstract][Full Text] [Related]
20. ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.
Zhang C; Peng L; Gu H; Wang J; Wang Y; Xu Z
Sci Rep; 2023 Jan; 13(1):1583. PubMed ID: 36709331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
